Nuwellis (NUWE) Revenue & Revenue Breakdown
Nuwellis Revenue Highlights
Latest Revenue (Y)
$8.86M
Latest Revenue (Q)
$2.37M
Nuwellis Revenue by Period
Nuwellis Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $8.86M | 3.76% |
| 2022-12-31 | $8.54M | 7.85% |
| 2021-12-31 | $7.92M | 6.45% |
| 2020-12-31 | $7.44M | 35.02% |
| 2019-12-31 | $5.51M | 10.26% |
| 2018-12-31 | $5.00M | 40.67% |
| 2017-12-31 | $3.55M | 175.64% |
| 2016-12-31 | $1.29M | 2084.75% |
| 2015-12-31 | $59.00K | -80.00% |
| 2014-12-31 | $295.00K | 400.00% |
| 2013-12-31 | $59.00K | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2011-12-31 | - | -100.00% |
| 2010-06-30 | $400.03K | 269.36% |
| 2009-06-30 | $108.30K | -74.34% |
| 2008-06-30 | $422.04K | -84.55% |
| 2007-06-30 | $2.73M | 117.99% |
| 2006-06-30 | $1.25M | 228.25% |
| 2005-06-30 | $381.76K | 1529.23% |
| 2004-06-30 | $23.43K | - |
Nuwellis generated $8.86M in revenue during NA 2023, up 3.76% compared to the previous quarter, and up 177.35% compared to the same period a year ago.
Nuwellis Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $2.37M | 7.89% |
| 2024-06-30 | $2.19M | 18.15% |
| 2024-03-31 | $1.86M | -27.21% |
| 2023-12-31 | $2.55M | 5.76% |
| 2023-09-30 | $2.41M | 16.24% |
| 2023-06-30 | $2.08M | 13.64% |
| 2023-03-31 | $1.83M | -21.93% |
| 2022-12-31 | $2.34M | 13.27% |
| 2022-09-30 | $2.06M | -6.69% |
| 2022-06-30 | $2.21M | 14.90% |
| 2022-03-31 | $1.93M | 17.30% |
| 2021-12-31 | $1.64M | -11.39% |
| 2021-09-30 | $1.85M | -26.12% |
| 2021-06-30 | $2.51M | 30.76% |
| 2021-03-31 | $1.92M | -6.16% |
| 2020-12-31 | $2.04M | 7.35% |
| 2020-09-30 | $1.90M | 2.20% |
| 2020-06-30 | $1.86M | 14.29% |
| 2020-03-31 | $1.63M | 19.24% |
| 2019-12-31 | $1.37M | 9.19% |
| 2019-09-30 | $1.25M | -25.34% |
| 2019-06-30 | $1.68M | 38.02% |
| 2019-03-31 | $1.22M | -18.95% |
| 2018-12-31 | $1.50M | 9.98% |
| 2018-09-30 | $1.36M | 24.02% |
| 2018-06-30 | $1.10M | 5.98% |
| 2018-03-31 | $1.04M | 24.79% |
| 2017-12-31 | $831.00K | -13.17% |
| 2017-09-30 | $957.00K | 10.76% |
| 2017-06-30 | $864.00K | -4.11% |
| 2017-03-31 | $901.00K | 20.78% |
| 2016-12-31 | $746.00K | 37.38% |
| 2016-09-30 | $543.00K | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | -100.00% |
| 2015-03-31 | $59.00K | -66.67% |
| 2014-12-31 | $177.00K | 200.00% |
| 2014-09-30 | $59.00K | 100.00% |
| 2014-06-30 | - | -100.00% |
| 2014-03-31 | $59.00K | 100.00% |
| 2013-12-31 | - | -100.00% |
| 2013-09-30 | $59.00K | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | -100.00% |
| 2011-09-30 | $-50.00K | - |
Nuwellis generated $2.37M in revenue during Q3 2024, up 7.89% compared to the previous quarter, and up 114.07% compared to the same period a year ago.
Nuwellis Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| HSCS | Heart Test Laboratories | $18.60M | - |
| NUWE | Nuwellis | $8.86M | $2.37M |
| RSLS | ReShape Lifesciences | $8.68M | $2.29M |
| INVO | INVO Bioscience | $3.02M | $1.58M |
| TNON | Tenon Medical | $2.93M | $887.00K |
| SINT | Sintx | $2.63M | $799.00K |
| NAOV | NanoVibronix | $2.28M | $376.00K |
| TIVC | Tivic Health Systems | $1.18M | $126.00K |
| HSDT | Helius Medical | $644.00K | $51.00K |
| BJDX | Bluejay Diagnostics | - | - |
| BBLG | Bone Biologics | - | - |